An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain

Summary

This study is an open-label, multicenter, extension study for subjects who completed NeurogesX Study C111 and received treatment with NGX-4010 (Capsaicin Patch) within 12 weeks (up to +7days) before entry into Study C114

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications